|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02162 KEYMED BIO-B
Nominal 
41.400 -2.300 (-5.263%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 54,682 | -83.284% | 327,124 | 100,000 | 0 | 0 |
| Cost of Sales | (3,736) | -75.122% | (15,017) | (2,537) | -- | -- |
| Gross Profit | 50,946 | -83.677% | 312,107 | 97,463 | -- | -- |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (3,399,789) | 11,148 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (27,748) | -- | |
| Share of Results of Asso. & JCEs | (1,698) | -19.027% | (2,097) | (8,811) | 0 | 0 | |
| Profit / (Loss) before Taxation | (330,524) | -- | 48,145 | 2,524 | (3,630,431) | (35,486) | |
| Taxation | (6,079) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (142) | -87.946% | (1,178) | 2,930 | 1,931 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (336,745) | -- | 46,967 | 5,454 | (3,628,500) | (35,486) | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | (32,759) | 0.040% | (32,746) | (15,935) | 4,173 | 320 |
| Depreciation & Amortisation | 46,336 | 72.863% | 26,805 | 14,902 | 10,482 | 8,470 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -129.000 | -- | 18.000 | 2.080 | -5,408.000 | -53.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 9.426 | -- | 12.062 | 13.016 | -- | -- |
| Remarks: | Real time quote last updated: 13/11/2024 16:17 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -336,745,000 |
| %Change | -- |
| EPS / (LPS) | RMB -1.290 |
| NBV Per Share (¥) | RMB 9.426 |